相关实验视频

Updated: Jun 15, 2025

Transcranial Pulse Stimulation for Alzheimer's Patients

Transcranial Pulse Stimulation for Alzheimer's Patients

Published on: April 4, 2025

对治疗与安慰剂之间的差异和节省时间的测量进行比较,以评估阿尔茨海默病治疗效果

Guogen Shan¹, Yahui Zhang¹, Guoqiao Wang²

¹Department of Biostatistics, University of Florida, Gainesville, FL, USA.

Journal of Alzheimer's disease reports

|June 13, 2025

概括

比较治疗和安慰剂效应的统计模型可以通过考虑"节省时间"指标来增强. 这些新的方法显示了可比或优越的统计能力,特别是更大的样本大小,可能会提高阿尔茨海默氏症药物发现效率.

科学领域:

生物统计学生物统计学
临床试验设计临床试验设计
药物经济学药物经济学

背景情况:

传统的统计模型通过比较治疗和安慰剂组来估计治疗效应.
节省时间指标提供了一种替代方法,通过分析疾病进展曲线来量化治疗益处.

研究的目的:

为了比较传统模型的统计假设测试性能与节省时间的措施.
在临床试验环境中评估节省时间方法的实用性.

主要方法:

使用了donanemab第二期和第三期试验的模拟数据.
分析了三个不同的治疗疾病进展轨迹.
在不同的样本大小中,传统模型和节省时间方法之间的统计能力进行了比较.

主要成果:

传统模型通常在小到中型样本大小下表现出更高的统计能力.
节省时间的方法在样本大小增加时实现类似的统计能力.
在某些具有较大样本规模的场景中,节省时间的方法可以优于传统模型.

结论:

节省时间的方法为在临床试验中评估治疗益处提供了可行的替代方案.
这些方法可能会提高药物发现的效率,特别是对于阿尔茨海默病.
建议在未来的阿尔茨海默氏症试验中进一步考虑节省时间指标.

关键词:

阿尔茨海默病的疾病阿尔茨海默病的疾病.效果大小效果大小的影响.假设测试测试假设测试节省时间,节省时间.治疗与安慰剂之间的差异

更多相关视频

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development

Published on: February 11, 2019

Analysis of Learning and Memory Ability in an Alzheimer's Disease Mouse Model using the Morris Water Maze

Analysis of Learning and Memory Ability in an Alzheimer's Disease Mouse Model using the Morris Water Maze

Published on: October 29, 2019

相关概念视频

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

The Placebo Effect

The Placebo Effect

The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.

Blind Procedures

Blind Procedures

Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...

Comparing the Survival Analysis of Two or More Groups

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

Blinding

Blinding

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.